ELIZABETH STRICKER: Open Payments
NPI 1427729599 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 55 payments from 16 companies in 2025. Trend: 2023 $1,029 · 2024 $1,211 · 2025 $1,081
Food & beverage: $1,038Education: $43
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $161 |
| Novartis Pharmaceuticals Corporation | 5 | $136 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $135 |
| Organon LLC | 10 | $122 |
| GENZYME CORPORATION | 4 | $107 |
| ABBVIE INC. | 3 | $87 |
| PFIZER INC. | 3 | $60 |
| Lilly USA, LLC | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
Products named: Bimzelx, COSENTYX, VTAMA, DUPIXENT, ILUMYA, CIBINQO, RINVOQ, TREMFYA.
Industry payments across AZ — which companies pay providers there.
